Page last updated: 2024-08-17

gliotoxin and B-Cell Chronic Lymphocytic Leukemia

gliotoxin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Ali, F; Araghi, M; Demirtas, D; Hilgarth, M; Hubmann, R; Jäger, U; Rendeiro, AF; Schmidl, C; Schnabl, S; Shehata, M; Staber, PB; Valent, P; Zielinski, C	1
Demirtas, D; Hilgarth, M; Hubmann, R; Jäger, U; Ponath, E; Reiter, M; Schnabl, S; Shehata, M; Sieghart, W; Valent, P; Zielinski, C	1

Other Studies

2 other study(ies) available for gliotoxin and B-Cell Chronic Lymphocytic Leukemia

Article	Year
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. Cells, 2020, 06-18, Volume: 9, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzazepines; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Female; Gliotoxin; Humans; Lectins, C-Type; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nuclear Receptor Subfamily 4, Group A, Member 1; Receptor, Notch2; Receptor, Notch3; Receptors, IgE; Regulatory Elements, Transcriptional; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured	2020
Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells. British journal of haematology, 2013, Volume: 160, Issue:5 Topics: Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Coculture Techniques; Depression, Chemical; DNA Mutational Analysis; Female; Gene Expression Regulation, Leukemic; Gliotoxin; Humans; Immunoglobulin Heavy Chains; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Proteins; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 1; Proteasome Endopeptidase Complex; Receptor, Notch2; Receptor, Notch3; Receptors, Notch; Stromal Cells; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured	2013

Article

Year

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.

Cells, 2020, 06-18, Volume: 9, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzazepines; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Female; Gliotoxin; Humans; Lectins, C-Type; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nuclear Receptor Subfamily 4, Group A, Member 1; Receptor, Notch2; Receptor, Notch3; Receptors, IgE; Regulatory Elements, Transcriptional; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured

2020

Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells.

British journal of haematology, 2013, Volume: 160, Issue:5

Topics: Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Coculture Techniques; Depression, Chemical; DNA Mutational Analysis; Female; Gene Expression Regulation, Leukemic; Gliotoxin; Humans; Immunoglobulin Heavy Chains; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Proteins; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 1; Proteasome Endopeptidase Complex; Receptor, Notch2; Receptor, Notch3; Receptors, Notch; Stromal Cells; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured

2013